Standout Papers

Potent antibody therapeutics by design 1984 2026 1998 2012 820
  1. Potent antibody therapeutics by design (2006)
    Paul J. Carter Nature reviews. Immunology
  2. Therapeutic antibodies for autoimmunity and inflammation (2010)
    Andrew C. Chan, Paul J. Carter Nature reviews. Immunology
  3. Next generation antibody drugs: pursuit of the 'high-hanging fruit' (2017)
    Paul J. Carter, Greg A. Lazar Nature Reviews Drug Discovery
  4. The use of double mutants to detect structural changes in the active site of the tyrosyl-tRNA synthetase (Bacillus stearothermophilus) (1984)
    Paul J. Carter, Greg Winter et al. Cell
  5. Alternative molecular formats and therapeutic applications for bispecific antibodies (2015)
    Christoph Spiess, Qianting Zhai et al. Molecular Immunology
  6. Designing antibodies as therapeutics (2022)
    Paul J. Carter, Arvind Rajpal Cell

Immediate Impact

44 by Nobel laureates 43 from Science/Nature 67 standout
Sub-graph 1 of 23

Citing Papers

De novo design of allosterically switchable protein assemblies
2024 StandoutNatureNobel
Organometallic anti-tumor agents: targeting from biomolecules to dynamic bioprocesses
2023 Standout
1 intermediate paper

Works of Paul J. Carter being referenced

Next generation antibody drugs: pursuit of the 'high-hanging fruit'
2017 Standout
The use of double mutants to detect structural changes in the active site of the tyrosyl-tRNA synthetase (Bacillus stearothermophilus)
1984 StandoutNobel

Author Peers

Author Last Decade Papers Cites
Paul J. Carter 2757 2853 1298 41 4.7k
Thomas Garrett 1826 2721 1761 48 5.4k
Robert F. Kelley 2186 4449 850 101 6.4k
Henry B. Lowman 2690 3427 847 78 5.7k
William F. Dall’Acqua 2365 2554 630 79 4.0k
Greg A. Lazar 2180 2071 738 42 3.4k
Nathalie Corvaı̈a 2415 2610 1548 71 4.9k
Mark S. Dennis 1513 2701 844 52 4.8k
Patrick Chames 1955 2483 1207 89 4.2k
Diane E. Milenic 4335 1862 1609 112 5.8k
Kathryn M. Ferguson 2229 5388 2732 50 7.9k

All Works

Loading papers...

Rankless by CCL
2026